A tumor is classified as HER2 protein over-expression by IHC positive (score 3+) when there is strong, complete, basolateral or lateral membrane staining in ≥10% of tumor cells in surgical specimen versus a cluster of at least five positive cells in a biopsy specimen. This evidence concerns the gene ERBB2 and neoplasm.